• Watch training video
  • See the features

Patient-focused features designed for ease of use

Adrenaclick® offers explicit instructions and coloring to guide patients in the heat of an anaphylactic emergency

Injector


Adrenaclick® helps ensure accurate delivery of epinephrine. The press-and-hold technique—press hard, hold in thigh 10 seconds—is designed to deliver the full dose of epinephrine in the correct location of the thigh.

Convenience and flexibility for your patients

Adrenaclick® is available as a single injector or as a convenient Two-Pack. Each Adrenaclick® comes in a crush-resistant carrying case designed so it can be carried separately or locked together as a Two-Pack. Additionally, Adrenaclick® comes in 2 dosage strengths:


0.15 mg for patients who weigh 33-66 pounds (15-30 kg) 		    
0.3 mg dose for patients who weigh 66 pounds (30 kg) or greater

Indication

Adrenaclick® (epinephrine injection, USP) is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g., triatoma, mosquitos), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media), and other allergens, as well as anaphylaxis to unknown substances (idiopathic anaphylaxis) or exercise-induced anaphylaxis.

Adrenaclick® is intended for immediate administration in patients with a history of anaphylactic reactions. Selection of the appropriate dosage strength is determined according to patient body weight. Such reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria, or angioedema.

Important Safety Information about Adrenaclick®

Adrenaclick® should only be injected into the anterolateral aspect of the thigh. Accidental injection into the hands or feet may result in loss of blood flow to the affected area and should be avoided. DO NOT INJECT INTO BUTTOCK. DO NOT INJECT INTRAVENOUSLY.

Epinephrine should be administered with caution to patients with cardiac arrhythmias, coronary artery or organic heart disease, or hypertension. In patients with coronary insufficiency or ischemic heart disease, epinephrine may precipitate or aggravate angina pectoris as well as produce ventricular arrhythmias. It should be recognized that the presence of these conditions is not a contraindication to epinephrine administration in an acute, life-threatening situation.

Adverse reactions to epinephrine include transient, moderate anxiety; apprehensiveness; restlessness; tremor; weakness; dizziness; sweating; palpitations; pallor; nausea and vomiting; headache, and/or respiratory difficulties.

The effects of epinephrine may be potentiated by tricyclic antidepressants, monoamine oxidase inhibitors, sodium levothyroxine, and certain antihistamines, notably chlorpheniramine, tripelennamine, and diphenhydramine.

Adrenaclick® is designed as an emergency supportive therapy only and is not a replacement or substitute for immediate medical care.

Since the dose of epinephrine delivered from Adrenaclick® is fixed, the physician should consider other forms of injectable epinephrine if doses lower than those available from Adrenaclick® are felt to be necessary (e.g., patients who weigh less than 15 kilograms, approximately 33 pounds).

IN ALL CASES, THE PHYSICIAN SHOULD INSTRUCT THE PATIENT AND/OR ANY OTHER PERSON WHO MIGHT BE IN A POSITION TO ADMINISTER THE EPINEPHRINE, IN THE PROPER USE OF Adrenaclick®.

Click here for full Prescribing Information for Adrenaclick®